The association of circulating endotoxin with the development of the adult respiratory distress syndrome.
Despite extensive investigation, the pathogenesis of the adult respiratory distress syndrome (ARDS) remains uncertain. As yet, there is no clear explanation of why some patients at risk for ARDS develop the syndrome, whereas others do not. Neutrophils and complement fragments have been implicated in the acute lung injury, but it is clear from published data that evidence of complement activation alone predicts neither the development nor the severity of ARDS. We investigated whether the combination of endotoxin, a leukocyte-priming agent, and complement fragments, leukocyte-stimulating agents, was associated with the development of ARDS. Ninety-eight patients were identified as being either at risk for the development of ARDS or having ARDS, and serial blood samples were obtained. There was no correlation between C5 fragments and the development of ARDS. C3 fragment levels were increased in 89% of the patients with ARDS, but they were also increased in 62% of patients at risk. Endotoxin was detected in 74% of the plasma samples obtained from patients at risk who subsequent developed ARDS and in 64% of the plasma samples obtained from the patients with ARDS. In contrast, only 22% of the plasma samples obtained from the patients at risk who did not develop ARDS had measurable endotoxin. We suggest that the combination of endotoxin and complement fragments may be one mechanism involved in the development of ARDS.
Parsons
P E
PE
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado.
Worthen
G S
GS
Moore
E E
EE
Tate
R M
RM
Henson
P M
PM
D000328:Adult; D000368:Aged; D003176:Complement C3 / Q000032:analysis; D003179:Complement C3b; D003182:Complement C5 / Q000032:analysis; D004731:Endotoxins / Q000097:blood*; D005260:Female; D006801:Humans; D008070:Lipopolysaccharides / Q000097:blood; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis; D012128:Respiratory Distress Syndrome / Q000097:blood*; D012307:Risk Factors
D003176:Complement C3; D003182:Complement C5; D004731:Endotoxins; D008070:Lipopolysaccharides; D010446:Peptide Fragments; C046821:complement C3f; D003179:Complement C3b